Question 1

How many shares of CNTA does GOLDMAN SACHS GROUP INC own?

Accepted Answer

GOLDMAN SACHS GROUP INC previously held 0 shares of CNTA (CENTESSA PHARMACEUTICALS PLC) before exiting the position in 2026-Q2.

Question 2

What is GOLDMAN SACHS GROUP INC's CNTA position worth?

Accepted Answer

GOLDMAN SACHS GROUP INC's CNTA position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is GOLDMAN SACHS GROUP INC buying or selling CNTA?

Accepted Answer

In 2026-Q2, GOLDMAN SACHS GROUP INC exited their CNTA position entirely (-100.0% change in shares).

Question 4

When did GOLDMAN SACHS GROUP INC first buy CNTA?

Accepted Answer

Based on available 13F filings, GOLDMAN SACHS GROUP INC first reported a position in CNTA in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$40.50	0
2026-Q1	Increased	1.1M	+46.9%	$45.5M	0.0%	$26.20	40
2025-Q4	Increased	779,001	+214.7%	$19.5M	0.0%	$24.74	46
2025-Q3	Decreased	247,555	-55.7%	$6M	0.0%	$24.40	0
2025-Q2	Increased	559,283	+39.2%	$7.3M	0.0%	$13.13	36
2025-Q1	Increased	401,764	+128.8%	$5.8M	0.0%	$14.59	44
2024-Q4	New	175,566	-	$2.9M	0.0%	$16.35	36

CNTA7 quarters

CNTA
7 quarters